0001264124-12-000077.txt : 20120302
0001264124-12-000077.hdr.sgml : 20120302
20120302194541
ACCESSION NUMBER: 0001264124-12-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120301
FILED AS OF DATE: 20120302
DATE AS OF CHANGE: 20120302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOLETTA MARK G
CENTRAL INDEX KEY: 0001236389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19700
FILM NUMBER: 12664525
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000881464
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330266089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9360 TOWNE CENTRE DR
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 6195522200
MAIL ADDRESS:
STREET 1: 9360 TOWNE CENTRE DR
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2012-03-01
0
0000881464
AMYLIN PHARMACEUTICALS INC
AMLN
0001236389
FOLETTA MARK G
9360 TOWNE CENTRE DR
SAN DIEGO
CA
92121
0
1
0
1
SVP, Chief Financial Officer
SVP, Chief Financial Officer
Common Stock
2012-03-01
4
S
0
1846
17.11
D
62490
D
Common Stock
3868.2
I
Indirect-401k
Common Stock
6445.1
I
by ESOP
Common Stock
110
I
by wife
Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of restricted stock units.
Includes 897 shares recently acquired under the Company's Employee Stock Purchase Plan.
These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
The reporting person acquired beneficial ownership of these shares in November, 2007.
By: /s/ Attorney-in-Fact, James R. Oehler For: Mark G. Foletta
2012-03-02